These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 30150770)
1. Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model. Schiaffino L; Bonafede R; Scambi I; Parrella E; Pizzi M; Mariotti R Sci Rep; 2018 Aug; 8(1):12875. PubMed ID: 30150770 [TBL] [Abstract][Full Text] [Related]
2. Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice. Bankole O; Scambi I; Parrella E; Muccilli M; Bonafede R; Turano E; Pizzi M; Mariotti R Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162978 [TBL] [Abstract][Full Text] [Related]
3. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. Lanzillotta A; Pignataro G; Branca C; Cuomo O; Sarnico I; Benarese M; Annunziato L; Spano P; Pizzi M Neurobiol Dis; 2013 Jan; 49():177-89. PubMed ID: 22971966 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Mancuso R; del Valle J; Modol L; Martinez A; Granado-Serrano AB; Ramirez-Núñez O; Pallás M; Portero-Otin M; Osta R; Navarro X Neurotherapeutics; 2014 Apr; 11(2):419-32. PubMed ID: 24414863 [TBL] [Abstract][Full Text] [Related]
5. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224 [TBL] [Abstract][Full Text] [Related]
6. Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis. Parrella E; Porrini V; Scambi I; Gennari MM; Gussago C; Bankole O; Benarese M; Mariotti R; Pizzi M Front Pharmacol; 2022; 13():1017364. PubMed ID: 36339574 [TBL] [Abstract][Full Text] [Related]
7. Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse model. Anzilotti S; Valsecchi V; Brancaccio P; Guida N; Laudati G; Tedeschi V; Petrozziello T; Frecentese F; Magli E; Hassler B; Cuomo O; Formisano L; Secondo A; Annunziato L; Pignataro G Neurobiol Dis; 2021 Nov; 159():105480. PubMed ID: 34411705 [TBL] [Abstract][Full Text] [Related]
8. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414 [TBL] [Abstract][Full Text] [Related]
9. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
10. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord. Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087 [TBL] [Abstract][Full Text] [Related]
11. Cromolyn sodium delays disease onset and is neuroprotective in the SOD1 Granucci EJ; Griciuc A; Mueller KA; Mills AN; Le H; Dios AM; McGinty D; Pereira J; Elmaleh D; Berry JD; Paganoni S; Cudkowicz ME; Tanzi RE; Sadri-Vakili G Sci Rep; 2019 Nov; 9(1):17728. PubMed ID: 31776380 [TBL] [Abstract][Full Text] [Related]
12. Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Novoselov SS; Mustill WJ; Gray AL; Dick JR; Kanuga N; Kalmar B; Greensmith L; Cheetham ME PLoS One; 2013; 8(8):e73944. PubMed ID: 24023695 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Zhao Z; Fu J; Li S; Li Z J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663 [TBL] [Abstract][Full Text] [Related]
14. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis. Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798 [TBL] [Abstract][Full Text] [Related]
15. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1 Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Song L; Chen L; Zhang X; Li J; Le W Biomed Res Int; 2014; 2014():483501. PubMed ID: 25057490 [TBL] [Abstract][Full Text] [Related]
17. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Gento-Caro Á; Vilches-Herrando E; Portillo F; González-Forero D; Moreno-López B Brain Pathol; 2022 May; 32(3):e13022. PubMed ID: 34585475 [TBL] [Abstract][Full Text] [Related]
18. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1 MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712 [TBL] [Abstract][Full Text] [Related]
19. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1 Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622 [TBL] [Abstract][Full Text] [Related]